Galen says takeover talks break down
Galen Holdings of the UK has called an end to talks with an unnamed buyer, thought to have been US generics specialist Barr Laboratories.
Galen Holdings of the UK has called an end to talks with an unnamed buyer, thought to have been US generics specialist Barr Laboratories.
Akzo Nobel's second-quarter results reveal increasing pressure on its drugs business and lead to speculation that it may consider a pharma spin-out.
US company Banner Pharmacaps has unveiled what it claims is the first controlled drug delivery system to be based on a softgel capsule platform.
UK software company Intelligensys has launched a new product that promises a step forward in the application of artificial intelligence technologies to pharmaceutical formulation and design.
LipoCore's Galacticle delivery technology is to be the subject of a feasibility study at one of the largest multinational drug manufacturers in the autumn